{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T21:01:02Z","timestamp":1785272462121,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care: Clinics in Office Practice"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.pop.2026.03.004","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T21:15:24Z","timestamp":1778188524000},"page":"431-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Kratom Use, Synthetic Cannabinoids (K2), and Trends in the Drug Supply"],"prefix":"10.1016","volume":"53","author":[{"given":"Timothy J.","family":"Kolosionek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra M.","family":"Amaducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.pop.2026.03.004_bib1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/15563650.2024.2412423","article-title":"2023 annual report of the National Poison Data System\u00ae (NPDS) from America\u2019s poison centers\u00ae: 41st annual report","volume":"62","author":"Gummin","year":"2024","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.pop.2026.03.004_bib2","article-title":"The noval psychoactive substances epidemic: a scientometric perspective","volume":"5","author":"Noeh","year":"2023","journal-title":"Addiction Neuroscience"},{"issue":"35","key":"10.1016\/j.pop.2026.03.004_bib3","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.15585\/mmwr.mm6935a5","article-title":"Notes from the field: phenibut exposures reported to poison centers - united States, 2009-2019","volume":"69","author":"Graves","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.pop.2026.03.004_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.15585\/mmwr.mm7304a5","article-title":"Notes from the field: cluster of severe illness from Neptune\u2019s fix tianeptine linked to synthetic cannabinoids - new Jersey, June-November 2023","volume":"73","author":"Counts","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.pop.2026.03.004_bib5","first-page":"19nr02507","article-title":"Kratom (Mitragyna speciosa): Friend or Foe?","volume":"22","author":"Sethi","year":"2020","journal-title":"Prim Care Companion CNS Disord"},{"issue":"1","key":"10.1016\/j.pop.2026.03.004_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40122-020-00151-x","article-title":"Kratom-pharmacology, clinical implications, and outlook: a comprehensive review","volume":"9","author":"Eastlack","year":"2020","journal-title":"Pain Ther"},{"key":"10.1016\/j.pop.2026.03.004_bib7","series-title":"LiverTox: clinical and research information on drug-induced liver injury","year":"2020"},{"key":"10.1016\/j.pop.2026.03.004_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/968786","article-title":"Following \u201cthe Roots\u201d of kratom (Mitragyna speciosa): the evolution of an enhancer from a traditional use to increase work and productivity in Southeast Asia to a recreational psychoactive drug in Western countries","volume":"2015","author":"Cinosi","year":"2015","journal-title":"BioMed Res Int"},{"issue":"3","key":"10.1016\/j.pop.2026.03.004_bib9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.psc.2022.04.002","article-title":"Kratom: substance of abuse or therapeutic plant?","volume":"45","author":"Gorelick","year":"2022","journal-title":"Psychiatr Clin North Am"},{"issue":"2","key":"10.1016\/j.pop.2026.03.004_bib10","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s40429-023-00476-5","article-title":"Kratom\u2019s emergence and persistence within the US polydrug epidemic","volume":"10","author":"Smith","year":"2023","journal-title":"Curr Addict Rep"},{"issue":"7","key":"10.1016\/j.pop.2026.03.004_bib11","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3390\/brainsci13070990","article-title":"Toxicity of synthetic cannabinoids in K2\/Spice: a systematic review","volume":"13","author":"de Oliveira","year":"2023","journal-title":"Brain Sci"},{"issue":"5","key":"10.1016\/j.pop.2026.03.004_bib12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/10408444.2020.1762539","article-title":"The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review","volume":"50","author":"Alves","year":"2020","journal-title":"Crit Rev Toxicol"},{"issue":"3","key":"10.1016\/j.pop.2026.03.004_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tips.2016.12.003","article-title":"Synthetic pot: not your grandfather\u2019s Marijuana","volume":"38","author":"Ford","year":"2017","journal-title":"Trends Pharmacol Sci"},{"issue":"20","key":"10.1016\/j.pop.2026.03.004_bib14","doi-asserted-by":"crossref","first-page":"6190","DOI":"10.3390\/molecules26206190","article-title":"The spicy story of cannabimimetic indoles","volume":"26","author":"Howlett","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.pop.2026.03.004_bib15","unstructured":"United Nations Office on Drugs and Crime, World Drug Report 2015 (United Nations publication, Sales No. E.15.XI.6). Available at: https:\/\/www.unodc.org\/documents\/wdr2015\/World_Drug_Report_2015.pdf."},{"key":"10.1016\/j.pop.2026.03.004_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2025.112701","article-title":"De facto opioids: characterization of novel 7-hydroxymitragynine and mitragynine pseudoindoxyl product marketing","volume":"272","author":"Hill","year":"2025","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pop.2026.03.004_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107849","article-title":"Kratom (Mitragyna speciosa): user demographics, use patterns, and implications for the opioid epidemic","volume":"208","author":"Garcia-Romeu","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.pop.2026.03.004_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/10550887.2021.1950263","article-title":"Kratom use disorder: a primer for primary care physicians","volume":"40","author":"Groff","year":"2022","journal-title":"J Addict Dis"},{"key":"10.1016\/j.pop.2026.03.004_bib19","unstructured":"Centers for Disease Control and Prevention. The Fentalog Study: A Subset of Nonfatal Suspected Opioid-Involved Overdoses with Toxicology Testing. Atlanta, GA: US Department of Health and Human Services, CDC; (2025, March, 17). Available at: https:\/\/www.cdc.gov\/overdose-prevention\/data-research\/facts-stats\/fentalog-study-dashboard.html (Accessed 1 April 2025)."},{"issue":"1","key":"10.1016\/j.pop.2026.03.004_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00414-015-1279-y","article-title":"The pharmacology and toxicology of kratom: from traditional herb to drug of abuse","volume":"130","author":"Warner","year":"2016","journal-title":"Int J Leg Med"},{"issue":"1","key":"10.1016\/j.pop.2026.03.004_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15563650.2015.1110590","article-title":"A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment","volume":"54","author":"Tait","year":"2016","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.pop.2026.03.004_bib22","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.psychres.2018.08.012","article-title":"Psychosis and synthetic cannabinoids","volume":"268","author":"Deng","year":"2018","journal-title":"Psychiatry Res"},{"issue":"1","key":"10.1016\/j.pop.2026.03.004_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40001-023-01443-6","article-title":"The synthetic cannabinoids menace: a review of health risks and toxicity","volume":"29","author":"Alzu\u2019bi","year":"2024","journal-title":"Eur J Med Res"},{"issue":"1","key":"10.1016\/j.pop.2026.03.004_bib24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/add.15082","article-title":"Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study","volume":"116","author":"Schimmel","year":"2021","journal-title":"Addiction"},{"issue":"40","key":"10.1016\/j.pop.2026.03.004_bib25","article-title":"Kratom","volume":"191","author":"Sanderson","year":"2019","journal-title":"CMAJ (Can Med Assoc J)"},{"issue":"10","key":"10.1016\/j.pop.2026.03.004_bib26","article-title":"Acquired type 1 Brugada syndrome induced by chronic high-dose kratom use","volume":"16","author":"Holton","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.pop.2026.03.004_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2025.112698","article-title":"Adverse clinical effects associated with the use of synthetic cannabinoids: a systematic review","volume":"272","author":"Prete","year":"2025","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.pop.2026.03.004_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/JAN.0000000000000333","article-title":"Historical and current perspectives of synthetic marijuana: critical review","volume":"31","author":"Vera","year":"2020","journal-title":"J Addict Nurs"},{"issue":"1","key":"10.1016\/j.pop.2026.03.004_bib29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MAJ.0000000000000466","article-title":"Synthetic cannabinoids","volume":"350","author":"Mills","year":"2015","journal-title":"Am J Med Sci"},{"issue":"17","key":"10.1016\/j.pop.2026.03.004_bib30","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.3390\/ijms21176115","article-title":"Molecular pharmacology of synthetic cannabinoids: delineating CB1 receptor-mediated cell signaling","volume":"21","author":"Walsh","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.pop.2026.03.004_bib31","first-page":"1223","article-title":"New psychoactive substances in pediatric patients","volume":"64","author":"Warrick","year":"2017","journal-title":"Pediatr Clin"},{"issue":"1","key":"10.1016\/j.pop.2026.03.004_bib32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5409\/wjcp.v5.i1.16","article-title":"Synthetic cannabinoids 2015: an update for pediatricians in clinical practice","volume":"5","author":"Castellanos","year":"2016","journal-title":"World J Clin Pediatr"},{"issue":"2","key":"10.1016\/j.pop.2026.03.004_bib33","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2690","article-title":"Neuropsychiatric sequelae in adolescents with acute synthetic cannabinoid toxicity","volume":"144","author":"Anderson","year":"2019","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.pop.2026.03.004_bib34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.annemergmed.2015.05.021","article-title":"Unintentional pediatric exposure to a synthetic cannabinoid (AB-PINACA) resulting in coma and intubation","volume":"66","author":"Thornton","year":"2015","journal-title":"Ann Emerg Med"},{"issue":"21","key":"10.1016\/j.pop.2026.03.004_bib35","doi-asserted-by":"crossref","first-page":"607","DOI":"10.15585\/mmwr.mm6721a4","article-title":"Notes from the field: outbreak of severe illness linked to the vitamin K antagonist brodifacoum and use of synthetic cannabinoids - illinois, March-April 2018","volume":"67","author":"Moritz","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.pop.2026.03.004_bib36","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/cpt.119","article-title":"Cannabinoids: friend or foe?","volume":"97","author":"Le Foll","year":"2015","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.pop.2026.03.004_bib37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-0035-1556753","article-title":"Pediatric toxicology: emerging trends","volume":"4","author":"Madden","year":"2015","journal-title":"J Pediatr Intensive Care"},{"issue":"6","key":"10.1016\/j.pop.2026.03.004_bib38","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1177\/0269881115574493","article-title":"Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample","volume":"29","author":"Winstock","year":"2015","journal-title":"J Psychopharmacol"},{"issue":"5","key":"10.1016\/j.pop.2026.03.004_bib39","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11920-016-0694-1","article-title":"Adverse effects of synthetic cannabinoids: management of acute toxicity and withdrawal","volume":"18","author":"Cooper","year":"2016","journal-title":"Curr Psychiatry Rep"},{"issue":"12","key":"10.1016\/j.pop.2026.03.004_bib40","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1080\/15563650.2022.2132768","article-title":"2021 annual report of the National Poison Data System\u00a9 (NPDS) from America\u2019s poison centers: 39th annual report","volume":"60","author":"Gummin","year":"2022","journal-title":"Clin Toxicol"}],"container-title":["Primary Care: Clinics in Office Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454326000175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454326000175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:39:41Z","timestamp":1785271181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095454326000175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0095454326000175"],"URL":"https:\/\/doi.org\/10.1016\/j.pop.2026.03.004","relation":{},"ISSN":["0095-4543"],"issn-type":[{"value":"0095-4543","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kratom Use, Synthetic Cannabinoids (K2), and Trends in the Drug Supply","name":"articletitle","label":"Article Title"},{"value":"Primary Care: Clinics in Office Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pop.2026.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}